Efferent therapy in the first-line drug treatment of metastatic colorectal cancer

The aim of this study is to analyse the efficacy of efferent therapy (hemosorption) as part of drug treatment in patients with metastatic colorectal cancer (mCRC) based on the use of standard first-line chemotherapy combined with the bevacizumab biosimilar. The study included 54 patients with histol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Z. S. Kotova, T. Yu. Semiglazova, I. A. Baldueva, D. H. Latipova, D. O. Yurlov, V. V. Semiglazov, G. M. Teletaeva, A. V. Novik, A. I. Semenova, S. A. Protsenko
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2018-07-01
Colecção:Медицинский совет
Assuntos:
metastatic colorectal cancer
hemosorption
bevacizumab biosimilar
first-line treatment
Acesso em linha:https://www.med-sovet.pro/jour/article/view/2554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados